Brennan Daniel J.
SEC CIK 1595612 · EDGAR
BoughtSold
Most active insiders at MDGL, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | FRIEDMAN PAUL A | Dir | — | $26.66M |
| 2 | Taub Rebecca | Dir | — | $21.68M |
| 3 | Sibold William John | Pres, CEO, Dir | — | $10.48M |
| 4 | BATE KENNETH | Dir | — | $8.03M |
| 5 | Levy Richard S | Dir | — | $7.36M |
| 6 | Dier Mardi | EVP, CFO | — | $3.77M |
| 7 | Huntsman Carole | Chief Commercial Off | — | $1.71M |
| 8 | Soergel David | Chief Medical Off | — | $952.0K |
| 9 | Kelley Shannon T | GC | — | $841.6K |
| 10 | Thakkar Rita | CAO | — | — |
| 11 | Brennan Daniel J. | Dir | — | — |
Transactions 57
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-06-18 16:12 | 2026-06-17 | MDGL | MADRIGAL PHARMACEUTICALS, INC. | Brennan Daniel J. | Dir | A - Grant | $0.00 | +404 | 1,371 | +42% | $0 |
| D | 2026-02-27 | 2026-02-25 | WAT | Waters Corporation | Brennan Daniel J. | Dir | A - Grant | $0.00 | +23 | 1,355 | +2% | $0 |
| D | 2026-01-05 | 2026-01-02 | WAT | Waters Corporation | Brennan Daniel J. | Dir | A - Grant | $0.00 | +307 | 1,332 | +30% | $0 |
| D | 2025-08-05 | 2025-08-01 | MDGL | MADRIGAL PHARMACEUTICALS, INC. | Brennan Daniel J. | Dir | A - Grant | $0.00 | +967 | 967 | New | $0 |
| DM | 2025-02-19 | 2025-02-19 | BSX | Boston Scientific | Brennan Daniel J. | EVP, CFO | M - OptEx | $25.61 | +60.5K | 283.7K | +27% | +$1.55M |
| DM | 2025-02-19 | 2025-02-18+ | BSX | Boston Scientific | Brennan Daniel J. | EVP, CFO | S - Sale+OE | $105.10 | -84.9K | 232.6K | -27% | -$8.92M |
| DM | 2025-02-18 | 2025-02-14+ | BSX | Boston Scientific | Brennan Daniel J. | EVP, CFO | F - Tax | $106.11 | -6,379 | 245.6K | -3% | -$676.9K |
| DM | 2025-02-18 | 2025-02-14+ | BSX | Boston Scientific | Brennan Daniel J. | EVP, CFO | M - OptEx | $0.00 | +13.2K | 249.8K | +6% | $0 |
| D | 2025-02-14 | 2025-02-12 | BSX | Boston Scientific | Brennan Daniel J. | EVP, CFO | M - OptEx | $0.00 | +3,654 | 245.1K | +2% | $0 |
| D | 2025-02-14 | 2025-02-12 | BSX | Boston Scientific | Brennan Daniel J. | EVP, CFO | F - Tax | $105.77 | -1,767 | 243.3K | -0.7% | -$186.9K |
| D | 2025-02-13 | 2025-02-11 | BSX | Boston Scientific | Brennan Daniel J. | EVP, CFO | A - Grant | $0.00 | +33.9K | 257.9K | +15% | $0 |
| D | 2025-02-13 | 2025-02-11 | BSX | Boston Scientific | Brennan Daniel J. | EVP, CFO | F - Tax | $105.98 | -16.4K | 241.5K | -6% | -$1.74M |
| D | 2025-02-13 | 2025-02-12 | BSX | Boston Scientific | Brennan Daniel J. | EVP, CFO | M - OptEx | $16.31 | +15.1K | 256.5K | +6% | +$246.1K |
| D | 2025-02-13 | 2025-02-12 | BSX | Boston Scientific | Brennan Daniel J. | EVP, CFO | S - Sale+OE | $105.07 | -15.1K | 241.5K | -6% | -$1.59M |
| D | 2025-01-06 | 2025-01-02 | WAT | Waters Corporation | Brennan Daniel J. | Dir | A - Grant | $0.00 | +319 | 1,025 | +45% | $0 |
| D | 2025-01-03 | 2025-01-01 | BSX | Boston Scientific | Brennan Daniel J. | EVP, CFO | F - Tax | $89.32 | -5,212 | 233.6K | -2% | -$465.5K |
| D | 2025-01-03 | 2025-01-03 | BSX | Boston Scientific | Brennan Daniel J. | EVP, CFO | S - Sale+OE | $89.86 | -9,689 | 223.9K | -4% | -$870.7K |
| D | 2025-01-03 | 2025-01-01 | BSX | Boston Scientific | Brennan Daniel J. | EVP, CFO | M - OptEx | $0.00 | +14.9K | 238.8K | +7% | $0 |
| DM | 2024-05-23 | 2024-05-22 | BSX | Boston Scientific | Brennan Daniel J. | EVP, CFO | M - OptEx | $21.33 | +64.5K | 288.4K | +29% | +$1.37M |
| DM | 2024-05-23 | 2024-05-22+ | BSX | Boston Scientific | Brennan Daniel J. | EVP, CFO | S - Sale+OE | $75.57 | -112.1K | 223.9K | -33% | -$8.47M |
| DM | 2024-02-20 | 2024-02-16+ | BSX | Boston Scientific | Brennan Daniel J. | EVP, CFO | M - OptEx | $6.82 | +26.2K | 268.8K | +11% | +$178.7K |
| D | 2024-02-20 | 2024-02-20 | BSX | Boston Scientific | Brennan Daniel J. | EVP, CFO | S - Sale+OE | $65.86 | -13.7K | 271.5K | -5% | -$899.8K |
| DM | 2024-02-20 | 2024-02-16+ | BSX | Boston Scientific | Brennan Daniel J. | EVP, CFO | F - Tax | $65.82 | -5,559 | 266.9K | -2% | -$365.9K |
| D | 2024-02-16 | 2024-02-14 | BSX | Boston Scientific | Brennan Daniel J. | EVP, CFO | M - OptEx | $0.00 | +4,362 | 266.5K | +2% | $0 |
| D | 2024-02-16 | 2024-02-14 | BSX | Boston Scientific | Brennan Daniel J. | EVP, CFO | F - Tax | $65.95 | -1,935 | 264.6K | -0.7% | -$127.6K |
| 2024-02-08 | 2024-02-06 | BSX | Boston Scientific | Brennan Daniel J. | EVP, CFO | F - Tax | $0.00 | -16.3K | 262.1K | -6% | $0 | |
| 2024-02-08 | 2024-02-06 | BSX | Boston Scientific | Brennan Daniel J. | EVP, CFO | A - Grant | $0.00 | +36.7K | 278.4K | +15% | $0 | |
| D | 2024-01-03 | 2024-01-02 | WAT | Waters Corporation | Brennan Daniel J. | Dir | A - Grant | $0.00 | +334 | 706 | +90% | $0 |
| D | 2024-01-02 | 2024-01-01 | BSX | Boston Scientific | Brennan Daniel J. | EVP, CFO | F - Tax | $57.81 | -8,199 | 241.7K | -3% | -$474.0K |
| D | 2024-01-02 | 2024-01-01 | BSX | Boston Scientific | Brennan Daniel J. | EVP, CFO | M - OptEx | $0.00 | +24.0K | 249.9K | +11% | $0 |
| DM | 2023-03-02 | 2023-03-01+ | BSX | Boston Scientific | Brennan Daniel J. | EVP, CFO | S - Sale+OE | $46.65 | -105.6K | 226.0K | -32% | -$4.93M |
| DM | 2023-03-02 | 2023-03-01 | BSX | Boston Scientific | Brennan Daniel J. | EVP, CFO | M - OptEx | $15.69 | +45.6K | 331.6K | +16% | +$715.8K |
| D | 2023-02-22 | 2023-02-21 | BSX | Boston Scientific | Brennan Daniel J. | EVP, CFO | F - Tax | $46.23 | -1,624 | 286.0K | -0.6% | -$75.1K |
| D | 2023-02-22 | 2023-02-21 | BSX | Boston Scientific | Brennan Daniel J. | EVP, CFO | M - OptEx | $0.00 | +3,661 | 287.6K | +1% | $0 |
| DM | 2023-02-21 | 2023-02-16+ | BSX | Boston Scientific | Brennan Daniel J. | EVP, CFO | M - OptEx | $0.00 | +12.5K | 280.6K | +5% | $0 |
| DM | 2023-02-21 | 2023-02-16+ | BSX | Boston Scientific | Brennan Daniel J. | EVP, CFO | F - Tax | $46.52 | -4,927 | 283.9K | -2% | -$229.2K |
| D | 2023-02-16 | 2023-02-15 | BSX | Boston Scientific | Brennan Daniel J. | EVP, CFO | F - Tax | $47.29 | -1,219 | 283.9K | -0.4% | -$57.6K |
| D | 2023-02-16 | 2023-02-15 | BSX | Boston Scientific | Brennan Daniel J. | EVP, CFO | S - Sale+OE | $47.14 | -7,572 | 276.3K | -3% | -$356.9K |
| DM | 2023-02-16 | 2023-02-15 | BSX | Boston Scientific | Brennan Daniel J. | EVP, CFO | M - OptEx | $4.77 | +11.7K | 285.1K | +4% | +$56.0K |
| D | 2023-01-05 | 2023-01-03 | WAT | Waters Corporation | Brennan Daniel J. | Dir | A - Grant | $0.00 | +318 | 372 | +589% | $0 |
| D | 2023-01-03 | 2023-01-01 | BSX | Boston Scientific | Brennan Daniel J. | EVP, CFO | M - OptEx | $0.00 | +13.1K | 277.4K | +5% | $0 |
| D | 2023-01-03 | 2023-01-01 | BSX | Boston Scientific | Brennan Daniel J. | EVP, CFO | F - Tax | $46.27 | -4,042 | 273.4K | -1% | -$187.0K |
| D | 2022-11-28 | 2022-11-23 | WAT | Waters Corporation | Brennan Daniel J. | Dir | A - Grant | $0.00 | +54 | 54 | New | $0 |
| 2022-03-03 | 2022-03-02 | BSX | Boston Scientific | Brennan Daniel J. | EVP, CFO | S - Sale | $44.03 | -11.0K | 264.3K | -4% | -$485.6K | |
| D | 2022-03-02 | 2022-02-28 | BSX | Boston Scientific | Brennan Daniel J. | EVP, CFO | F - Tax | $44.17 | -1,988 | 275.3K | -0.7% | -$87.8K |
| D | 2022-03-02 | 2022-02-28 | BSX | Boston Scientific | Brennan Daniel J. | EVP, CFO | M - OptEx | $0.00 | +4,481 | 277.3K | +2% | $0 |
| DM | 2022-02-24 | 2022-02-22 | BSX | Boston Scientific | Brennan Daniel J. | EVP, CFO | M - OptEx | $14.51 | +53.2K | 326.0K | +19% | +$771.8K |
| D | 2022-02-24 | 2022-02-22 | BSX | Boston Scientific | Brennan Daniel J. | EVP, CFO | S - Sale+OE | $42.75 | -53.2K | 272.8K | -16% | -$2.27M |
| D | 2022-02-23 | 2022-02-21 | BSX | Boston Scientific | Brennan Daniel J. | EVP, CFO | F - Tax | $42.55 | -1,624 | 272.8K | -0.6% | -$69.1K |
| D | 2022-02-23 | 2022-02-21 | BSX | Boston Scientific | Brennan Daniel J. | EVP, CFO | M - OptEx | $0.00 | +3,661 | 274.4K | +1% | $0 |
| DM | 2022-02-22 | 2022-02-17+ | BSX | Boston Scientific | Brennan Daniel J. | EVP, CFO | F - Tax | $42.70 | -3,677 | 270.8K | -1% | -$157.0K |
| DM | 2022-02-22 | 2022-02-17+ | BSX | Boston Scientific | Brennan Daniel J. | EVP, CFO | M - OptEx | $0.00 | +8,289 | 270.8K | +3% | $0 |
| D | 2022-02-17 | 2022-02-15 | BSX | Boston Scientific | Brennan Daniel J. | EVP, CFO | F - Tax | $44.01 | -1,219 | 275.3K | -0.4% | -$53.6K |
| DM | 2022-02-17 | 2022-02-15+ | BSX | Boston Scientific | Brennan Daniel J. | EVP, CFO | M - OptEx | $4.68 | +16.3K | 278.4K | +6% | +$76.5K |
| DM | 2022-02-17 | 2022-02-15+ | BSX | Boston Scientific | Brennan Daniel J. | EVP, CFO | S - Sale+OE | $43.60 | -21.3K | 266.2K | -7% | -$929.7K |
| D | 2022-01-03 | 2022-01-01 | BSX | Boston Scientific | Brennan Daniel J. | EVP, CFO | M - OptEx | $0.00 | +13.2K | 276.4K | +5% | $0 |
| D | 2022-01-03 | 2022-01-01 | BSX | Boston Scientific | Brennan Daniel J. | EVP, CFO | F - Tax | $42.48 | -4,057 | 272.4K | -1% | -$172.3K |
Purchase Sale Sale after option exercise All abbreviations